{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:41:29Z","timestamp":1770961289886,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Onxeo SA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s12325-017-0585-9","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T06:52:27Z","timestamp":1500447147000},"page":"2022-2032","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of the Systemic and Local Pharmacokinetics of Clonidine Mucoadhesive Buccal Tablets with Reference Clonidine Oral Tablets in Healthy Volunteers: An Open-Label Randomised Cross-Over Trial"],"prefix":"10.1007","volume":"34","author":[{"given":"B\u00e9rang\u00e8re","family":"Vasseur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia","family":"Houdas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Harries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan Yesiltas","family":"Emul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-4684","authenticated-orcid":false,"given":"Simon","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"issue":"S9","key":"585_CR1","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"S Sonis","year":"2004","unstructured":"Sonis S, Elting L, Keefe D, Peterson D, Schubert M, Hauer-Jensen M, Bekele B, Raber-Durlacher J, Donnelly J, Rubenstein E. Perspectives on cancer therapy-induced mucosal injury. Cancer. 2004;100(S9):1995\u20132025.","journal-title":"Cancer"},{"issue":"1","key":"585_CR2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.radonc.2016.04.001","volume":"120","author":"D Moslemi","year":"2016","unstructured":"Moslemi D, Nokhandani A, Otaghsaraei M, Moghadamnia Y, Kazemi S, Moghadamnia A. Management of chemo\/radiation-induced oral mucositis in patients with head and neck cancer: a review of the current literature. Radiother Oncol. 2016;120(1):13\u201320.","journal-title":"Radiother Oncol"},{"issue":"8","key":"585_CR3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"121","author":"R Lalla","year":"2014","unstructured":"Lalla R, Bowen J, Barasch A, Elting L, Epstein J, Keefe D, McGuire D, Migliorati C, Nicolatou-Galitis O, Peterson D, Raber-Durlacher J, Sonis S, Elad S. MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;121(8):1453\u201361.","journal-title":"Cancer"},{"issue":"1\u20132","key":"585_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-3959(03)00221-5","volume":"105","author":"P Lavand\u2019homme","year":"2003","unstructured":"Lavand\u2019homme P, Eisenach J. Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression. Pain. 2003;105(1\u20132):247\u201354.","journal-title":"Pain"},{"issue":"5","key":"585_CR5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bbi.2006.09.001","volume":"21","author":"A Romero-Sandoval","year":"2007","unstructured":"Romero-Sandoval A, Eisenach J. Clonidine reduces hypersensitivity and alters the balance of pro- and anti-inflammatory leukocytes after local injection at the site of inflammatory neuritis. Brain Behav Immun. 2007;21(5):569\u201380.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"585_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2125.1978.tb04589.x","volume":"6","author":"M Frisk-Holmberg","year":"1978","unstructured":"Frisk-Holmberg M, Edlund P, Paalzow L. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients. Br J Clin Pharmacol. 1978;6(3):227\u201332.","journal-title":"Br J Clin Pharmacol"},{"issue":"5720","key":"585_CR7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/bmj.3.5720.440","volume":"3","author":"A Macdougall","year":"1970","unstructured":"Macdougall A, Addis G, Mackay N, Dymock I, Turpie A, Ballingall D, Maclennan W, Whiting B, Macarthur J. Treatment of hypertension with clonidine. BMJ. 1970;3(5720):440\u20132.","journal-title":"BMJ"},{"key":"585_CR8","unstructured":"Boehringer Ingelheim Limited. Catapres Tablets 100mcg\u2014summary of Product Characteristics. 2014."},{"issue":"7","key":"585_CR9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-015-0236-8","volume":"54","author":"S Kanji","year":"2015","unstructured":"Kanji S, Hayes M, Ling A, Shamseer L, Chant C, Edwards D, Edwards S, Ensom M, Foster D, Hardy B, Kiser T, la Porte C, Roberts J, Shulman R, Walker S, Zelenitsky S, Moher D. Reporting guidelines for clinical pharmacokinetic studies: the ClinPK statement. Clin Pharmacokinet. 2015;54(7):783\u201395.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"585_CR10","first-page":"1","volume":"29","author":"E Diletti","year":"1991","unstructured":"Diletti E, Hauschke D, Steinijans V. Sample size determination for bioequivalence assessment by means of confidence intervals. Int J Clin Pharmacol Therapy Toxicol. 1991;29(1):1\u20138.","journal-title":"Int J Clin Pharmacol Therapy Toxicol"},{"key":"585_CR11","unstructured":"Public Assessment Report. Decentralised procedure, UK\/H\/1448\/01\/DC, UK licence number: PL 17507\/0094."},{"key":"585_CR12","doi-asserted-by":"crossref","unstructured":"Giralt J, Tao Y, Bensadoun R, Lalla R, Mahmut Ozsahin E, Pajkos G, Kortmann R, Contreras-Martinez J, Ceruse P, Zasadny X, Arias de la Vega F, Attali P, Vasseur B. Mucoadhesive clonidine (Clonidine Lauriad) in the prevention of severe radiomucositis in head and neck cancer patients: a phase II randomized trial. J Clin Oncol. 2015;33(suppl; abstr 6058).","DOI":"10.1200\/jco.2015.33.15_suppl.6058"},{"key":"585_CR13","doi-asserted-by":"crossref","unstructured":"Tao Y, Giralt J, Bensadoun J, Lalla R, Ozsahin E, Pajkos G, Kortmann R, Contreras-Martinez J, C\u00e9ruse P, Zasadny X, Arias de la Vega F, Vasseur B, Houdas L, Henke M. Safety profile support efficacy of gingival clonidine tablet to prevent severe oral mucositis in HNC. In: ESTRO 35, Turin, Italy. 2016.","DOI":"10.1016\/S0167-8140(16)31886-2"},{"issue":"10","key":"585_CR14","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/cid\/cis205","volume":"54","author":"J Vazquez","year":"2012","unstructured":"Vazquez J, Sobel J. Miconazole mucoadhesive tablets: a novel delivery system. Clin Infect Dis. 2012;54(10):1480\u20134.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"585_CR15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/1735-5362.189284","volume":"11","author":"S Abbasi","year":"2016","unstructured":"Abbasi S, Yousefi G, Ansari AA, Mohammadi-Samani SS. Formulation and in vitro evaluation of a fast-disintegrating\/sustained dual release bucoadhesive bilayer tablet of captopril for treatment of hypertension crises. Res Pharm Sci. 2016;11(4):274\u201383.","journal-title":"Res Pharm Sci"},{"key":"585_CR16","unstructured":"Lemarchand C, Singlas E, Costantini D, Dufour A, Attali P. Plasma, saliva and labial mucosa pharmacokinetics and pharmacodynamics of acyclovir Lauriad\u00ae mucoadhesive buccal tablet in healthy volunteers. J Clin Pharmacol Clin Pharm. 2014;1(1)."},{"issue":"2","key":"585_CR17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1464-410X.2011.10837.x","volume":"110","author":"W Dinsmore","year":"2012","unstructured":"Dinsmore W, Wyllie M. The long-term efficacy and safety of a testosterone mucoadhesive buccal tablet in testosterone-deficient men. Br J Urol Int. 2012;110(2):162\u20139.","journal-title":"Br J Urol Int"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-017-0585-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0585-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0585-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T18:52:14Z","timestamp":1569869534000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-017-0585-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1007\/s12325-017-0585-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}